Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia

[1]  T. Arumugam,et al.  Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke , 2014, Experimental & Translational Stroke Medicine.

[2]  S. Phipps,et al.  RAGE and TLRs: relatives, friends or neighbours? , 2013, Molecular immunology.

[3]  Sung-Chun Tang,et al.  Evidence for a detrimental role of TLR8 in ischemic stroke , 2013, Experimental Neurology.

[4]  Jianling Xie,et al.  Cellular signalling of the receptor for advanced glycation end products (RAGE). , 2013, Cellular signalling.

[5]  M. Mattson,et al.  Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke , 2013, Cell Death and Disease.

[6]  M. Mattson,et al.  Functional Role of Soluble Receptor for Advanced Glycation End Products in Stroke , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[7]  F. Nimmerjahn,et al.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system? , 2013, Nature Reviews Immunology.

[8]  M. Mattson,et al.  Intravenous immunoglobulin protects neurons against amyloid beta‐peptide toxicity and ischemic stroke by attenuating multiple cell death pathways , 2012, Journal of neurochemistry.

[9]  A. Nakano,et al.  Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  Qing-Wu Yang,et al.  Toll-like receptors in cerebral ischemic inflammatory injury , 2011, Journal of Neuroinflammation.

[11]  J. A. Nogueira-Machado,et al.  HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation , 2011, Expert opinion on therapeutic targets.

[12]  Sung-Chun Tang,et al.  Evidence that γ-Secretase-Mediated Notch Signaling Induces Neuronal Cell Death via the Nuclear Factor-κB-Bcl-2-Interacting Mediator of Cell Death Pathway in Ischemic Stroke , 2011, Molecular Pharmacology.

[13]  D. Maric,et al.  Disruption of downstream MyD88 or TRIF Toll-like receptor signaling does not protect against cerebral ischemia , 2011, Brain Research.

[14]  Pedro Ramos-Cabrer,et al.  Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke. , 2011, Clinical immunology.

[15]  M. Ballow,et al.  Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes. , 2011, Clinical immunology.

[16]  Y. Shoenfeld,et al.  IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients , 2011, Journal of Clinical Immunology.

[17]  T. Gerriets,et al.  Intravenous Immunoglobulin Reduces Infarct Volume but Not Edema Formation in Acute Stroke , 2009, Neuroimmunomodulation.

[18]  S. Miescher,et al.  Intravenous immunoglobulins – understanding properties and mechanisms , 2009, Clinical and experimental immunology.

[19]  Sung-Chun Tang,et al.  TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY , 2009, Shock.

[20]  S. Kaveri,et al.  DC-SIGN and α2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells , 2009, Proceedings of the National Academy of Sciences.

[21]  Sung-Chun Tang,et al.  Toll-like receptors in neurodegeneration , 2009, Brain Research Reviews.

[22]  M. Mattson,et al.  Toll-Like Receptor 3 Is a Negative Regulator of Embryonic Neural Progenitor Cell Proliferation , 2008, The Journal of Neuroscience.

[23]  S. Kaveri,et al.  Modulation of the cellular immune system by intravenous immunoglobulin. , 2008, Trends in immunology.

[24]  Shizuo Akira,et al.  Signaling to NF-?B by Toll-like receptors , 2007 .

[25]  R. Nitsch,et al.  Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia , 2007, Journal of Neuroimmunology.

[26]  M. Mattson,et al.  Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death , 2007, Proceedings of the National Academy of Sciences.

[27]  M. Mattson,et al.  Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits , 2007, Proceedings of the National Academy of Sciences.

[28]  M. Mattson,et al.  The organotellurium compound ammonium trichloro(dioxoethylene‐0,0′) tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice , 2007, Journal of neurochemistry.

[29]  R. Sidman,et al.  Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis , 2006, The Journal of cell biology.

[30]  C. Ballantyne,et al.  Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion. , 2004, American journal of physiology. Heart and circulatory physiology.

[31]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[32]  M. Bogoyevitch,et al.  Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. , 2004, Biochimica et biophysica acta.

[33]  Song Jiang,et al.  Toll-like receptor signaling in cell proliferation and survival. , 2010, Cytokine.

[34]  Shizuo Akira,et al.  Signaling to NF-kappaB by Toll-like receptors. , 2007, Trends in molecular medicine.